A Phase 3 meditation of Avastin (Ge...
A Phase 3 meditation of Avastin (Genentech, Inc., southern San Francisco, CA, bevacizumab, rhuMAb-VEGF) in relapsed metastatic breast cancer exposes did not meet its primary efficacy endpoint of progression-free survival. The application of mind randomized 462 women with metastatic breast cancer, who had previously received
|